For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.

The company that makes waistline-shrinking Ozempic is taking advantage of shrinking valuations for green energy companies.

Novo Holdings, a shareholder with a 77% stake in weight-loss wonderdrug-maker Novo Nordisk, is investing $290 million in renewable energy as stocks in green energy companies take a dip, Bloomberg reported. As Europe's newly minted most-valuable company, Novo Nordisk is probably feeling it can afford a roll of the dice.

Continue reading

Source Fool.com